about
Immunomic analysis of human sarcomaDNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoterNY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimensImmunotherapy in Multiple Myeloma Using Cancer-Testis AntigensImmunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissuesCancer/testis antigens: an expanding family of targets for cancer immunotherapyThe XAGE family of cancer/testis-associated genes: alignment and expression profile in normal tissues, melanoma lesions and Ewing's sarcomamRNA expression of tumor-associated antigens in melanoma tissues and cell linesMethylation mattersMAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancerExpression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas.Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients.Identification and characterization of 9D7, a novel human protein overexpressed in renal cell carcinoma.Identification of cancer/testis genes by database mining and mRNA expression analysis.Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model.Human tumor antigens for cancer vaccine development.Identification of cancer/testis-antigen genes by massively parallel signature sequencing.CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis.Current status of linkage studies in hereditary prostate cancer.Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells.A novel tumour associated leucine zipper protein targeting to sites of gene transcription and splicing.NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancer.Cancer/testis antigens: structural and immunobiological properties.Understanding cancer metastasis: an urgent need for using differential gene expression analysis.Inhibition of the receptor tyrosine kinase ROR1 by anti-ROR1 monoclonal antibodies and siRNA induced apoptosis of melanoma cellsIdentification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen.Transduction of an HLA-DP4-restricted NY-ESO-1-specific TCR into primary human CD4+ lymphocytes.Expression of cancer-testis antigens MAGEA1, MAGEA3, ACRBP, PRAME, SSX2, and CTAG2 in myxoid and round cell liposarcoma.Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen.Analysis of the B-cell repertoire against antigens expressed by human neoplasms.Tumor-specific shared antigenic peptides recognized by human T cells.Enhancing antitumor immune responses: intracellular peptide delivery and identification of MHC class II-restricted tumor antigens.CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production.Polymeric structure and host Toll-like receptor 4 dictate immunogenicity of NY-ESO-1 antigen in vivoMonitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.Cancer/testis (CT) antigens, carcinogenesis and spermatogenesis.Immunohistochemistry in melanocytic proliferative lesions.Developing recombinant and synthetic vaccines for the treatment of melanoma.Targeted therapy for epithelial ovarian cancer.Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines
P2860
Q24554211-43DE8FC8-B546-4C87-B788-679E0BC31AAEQ24554402-3746AF80-32CF-4BCF-8885-0E3C2A675754Q24649090-A84A3675-B3EA-4B63-B397-03E97D5DBE94Q26774913-53A597C5-64D3-4FF5-8E2E-81F0A3EC511DQ28188712-9A137D7C-DD4B-453B-8C53-D6E8CC040FCCQ28215652-9C319566-3F52-47C1-974D-2FD59E2C1912Q28216604-ED305DBA-6C3F-45DB-AC56-9341BD77D4C9Q28218733-6A0577EE-E340-4478-864B-4A39E285B02FQ28364163-382F2059-52EF-4EAB-ACCD-3B1D5B01B498Q28478930-4AA7C8FB-3272-4491-A7E3-D29AFF84F9BAQ30706370-E645FC39-F82C-45CE-BBED-2FAF251BAB60Q30785776-1D15EC4F-DC3A-4C03-9E9B-4C4BE568E5D0Q30790800-D4A3A4A0-027F-48FE-A8B3-5C9CA0D0C7FBQ31045922-C27D9C7C-637B-4F41-B462-F3EB31594D90Q33646069-05E98622-385D-4AB0-A307-3163E590B1B1Q33776127-7D26C96A-801A-4B26-941A-E460E7E54CC1Q33841222-3DB18475-5006-409E-B3E4-B72C703756DFQ33892059-CE5CBA1B-8340-42DB-B4D7-FD8334C49927Q34078544-1B6D9FFD-A61A-43F0-9465-7ABF82BB5BA3Q34108458-33B6CA1C-6389-4B85-B163-DAA3C8737FD5Q34130453-BAADA217-F6AF-40BD-AE6C-9890268EF196Q34325790-CC8FF91A-1ED2-422C-9089-3E4A8B519250Q34568997-229AD009-2936-401A-BF0E-3C8576F0D5CCQ34580473-2DCE257B-1B61-40E4-BF11-561478D8ADE9Q34674715-62787AE2-6B92-464F-8721-D418F24F52F7Q34721861-4B035C1F-AD30-426B-A50C-9EB67E6B4113Q34795354-8E93EE2D-B68E-4CE7-9D2A-A8AB9B053740Q34870799-9E418250-F0F0-41E7-9BBF-A117321CD05BQ35005912-E87F7BEC-C028-4399-8A92-B15430BCC6CDQ35005922-BFC0AF09-7332-4414-B299-A2A117D18CDDQ35005926-B18E82BA-FA7F-4D24-A716-E3C3418589CFQ35005930-B621F2EC-A1C6-419F-B9E1-9DFDE0ECAEB4Q35048637-D28F97A7-D220-45A6-9FB4-96D001474E0CQ35423276-086C6C89-72A7-4C31-B5AF-AC1D53BDAABEQ35693584-F40D4CC4-D843-4578-9591-18670E1E7C7AQ35733359-238C357C-2D77-4F97-91F5-E72AE2A9C8E3Q35798186-E17C0C48-A230-4F14-AFEF-80D6869CE4C7Q35946196-4AFA1B04-61DA-48DE-A82F-B2B0BAC0744AQ36158708-71B6CA85-D303-433F-8811-C126B0DA6605Q36327142-AFC6B07C-1DCB-4522-9524-C0B34EA20CAD
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
LAGE-1, a new gene with tumor specificity
@ast
LAGE-1, a new gene with tumor specificity
@en
LAGE-1, a new gene with tumor specificity
@nl
type
label
LAGE-1, a new gene with tumor specificity
@ast
LAGE-1, a new gene with tumor specificity
@en
LAGE-1, a new gene with tumor specificity
@nl
prefLabel
LAGE-1, a new gene with tumor specificity
@ast
LAGE-1, a new gene with tumor specificity
@en
LAGE-1, a new gene with tumor specificity
@nl
P2093
P2860
P1476
LAGE-1, a new gene with tumor specificity
@en
P2093
D Godelaine
E De Plaen
P2860
P304
P356
10.1002/(SICI)1097-0215(19980610)76:6<903::AID-IJC22>3.0.CO;2-1
P407
P50
P577
1998-06-01T00:00:00Z